Get Symlin Online

Symlin (pramlintide) is a synthetic analog of amylin, a hormone normally co-secreted with insulin by the pancreas. It slows gastric emptying, suppresses post-meal glucagon release, and reduces appetite, all of which work together to lower blood sugar levels after meals.

Symlin is FDA-approved for adults with type 2 or type 1 diabetes who use mealtime insulin but have not achieved adequate blood sugar control. It is not a replacement for insulin and is always used in combination with it.

Symlin is injected subcutaneously immediately before each major meal using a separate syringe from insulin. It should never be mixed in the same syringe as insulin because the two are not compatible.

The most common side effects include nausea, vomiting, and loss of appetite, especially when starting treatment. Serious hypoglycemia is also a risk, particularly in the first few hours after injection, which is why mealtime insulin doses are typically reduced when Symlin is started.

Yes. When starting Symlin, your physician will typically recommend reducing your mealtime insulin dose by 50 percent to lower the risk of hypoglycemia. Your dose can be gradually adjusted based on blood sugar monitoring and tolerability.

Symlin is not recommended for people who have hypoglycemia unawareness, gastroparesis, or poor compliance with glucose monitoring or insulin therapy. These conditions increase the risk of serious complications when using pramlintide.

Symlin can support modest weight loss as a secondary benefit because it slows digestion and promotes a feeling of fullness. However, it is not approved as a weight loss medication and is prescribed specifically for blood sugar management in insulin-using diabetic patients.

Doctronic uses AI-assisted evaluation to gather detailed information about your symptoms and medical history, which is then reviewed by a licensed physician. If treatment is appropriate, the physician creates a personalized plan, which may include a prescription sent to your pharmacy.